Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 389

1.

Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).

Kinguchi S, Wakui H, Ito Y, Kondo Y, Azushima K, Osada U, Yamakawa T, Iwamoto T, Yutoh J, Misumi T, Aoki K, Yasuda G, Yoshii T, Yamada T, Ono S, Shibasaki-Kurita T, Hosokawa S, Orime K, Hanaoka M, Sasaki H, Inazumi K, Yamada T, Kobayashi R, Ohki K, Haruhara K, Kobayashi Y, Yamanaka T, Terauchi Y, Tamura K.

Cardiovasc Diabetol. 2019 Aug 27;18(1):110. doi: 10.1186/s12933-019-0912-3.

2.

The efficacy and safety of luseogliflozin and sitagliptin depending on the sequence of administration in patients with type 2 diabetes mellitus: a randomized controlled pilot study.

Takihata M, Terauchi Y.

Expert Opin Pharmacother. 2019 Aug 26:1-10. doi: 10.1080/14656566.2019.1656717. [Epub ahead of print]

PMID:
31450983
3.

Influence of Timing of Insulin Initiation on Long-term Glycemic Control in Japanese Patients with Type 2 Diabetes: A Retrospective Cohort Study.

Miyazaki T, Shirakawa J, Nagakura J, Shibuya M, Kyohara M, Okuyama T, Togashi Y, Nakamura A, Kondo Y, Satoh S, Nakajima S, Taguri M, Terauchi Y.

Intern Med. 2019 Jul 22. doi: 10.2169/internalmedicine.3060-19. [Epub ahead of print]

4.

Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study.

Suzuki J, Yamakawa T, Oba M, Nagakura J, Shigematsu E, Tamura H, Takahashi K, Okamoto Y, Sakamoto R, Shinoda M, Takano T, Kadonosono K, Terauchi Y.

Endocr J. 2019 Jul 4. doi: 10.1507/endocrj.EJ18-0309. [Epub ahead of print]

5.

Proinsulin is sensitive to reflect glucose intolerance.

Nakamura A, Miyoshi H, Ukawa S, Nakamura K, Nakagawa T, Terauchi Y, Tamakoshi A, Atsumi T.

J Diabetes Investig. 2019 Jun 21. doi: 10.1111/jdi.13106. [Epub ahead of print]

6.

Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice.

Omori K, Nakamura A, Miyoshi H, Takahashi K, Kitao N, Nomoto H, Kameda H, Cho KY, Takagi R, Hatanaka KC, Terauchi Y, Atsumi T.

Metabolism. 2019 Sep;98:27-36. doi: 10.1016/j.metabol.2019.06.006. Epub 2019 Jun 14.

PMID:
31202833
7.

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

Aroda VR, Rosenstock J, Terauchi Y, Altuntas Y, Lalic NM, Morales Villegas EC, Jeppesen OK, Christiansen E, Hertz CL, Haluzík M; PIONEER 1 Investigators.

Diabetes Care. 2019 Sep;42(9):1724-1732. doi: 10.2337/dc19-0749. Epub 2019 Jun 11.

PMID:
31186300
8.

Causes of death and estimated life expectancy among people with diabetes: A retrospective cohort study in a diabetes clinic.

Goto A, Takao T, Yoshida Y, Kawazu S, Iwamoto Y, Terauchi Y.

J Diabetes Investig. 2019 May 21. doi: 10.1111/jdi.13077. [Epub ahead of print]

9.
10.

Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study.

Takai M, Ishikawa M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T, Uehara G, Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T, Takeda H, Tanaka K, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, Minagawa F, Minami N, Miyairi Y, Mokubo A, Motomiya T, Waseda M, Miyakawa M, Terauchi Y, Tanaka Y, Matsuba I.

J Clin Med Res. 2019 May;11(5):311-320. doi: 10.14740/jocmr3677. Epub 2019 Apr 14.

11.

Usefulness of antidiabetic alpha-glucosidase inhibitors: a review on the timing of administration and effects on gut hormones.

Aoki K, Sato H, Terauchi Y.

Endocr J. 2019 May 28;66(5):395-401. doi: 10.1507/endocrj.EJ19-0041. Epub 2019 Apr 23.

12.

Drug-induced hyperglycemia in the Japanese Adverse Drug Event Report database: association of evelolimus use with diabetes.

Konishi H, Shirakawa J, Arai M, Terauchi Y.

Endocr J. 2019 Jun 28;66(6):571-574. doi: 10.1507/endocrj.EJ18-0553. Epub 2019 Apr 2.

13.

Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study.

Terauchi Y, Utsunomiya K, Yasui A, Seki T, Cheng G, Shiki K, Lee J.

Diabetes Ther. 2019 Jun;10(3):951-963. doi: 10.1007/s13300-019-0604-8. Epub 2019 Mar 25.

14.

PREVALENCE OF OBSTRUCTIVE SLEEP APNEA DETERMINED BY THE WATCHPAT IN NONOBESE JAPANESE PATIENTS WITH POOR GLUCOSE CONTROL AND TYPE 2 DIABETES.

Shinoda M, Yamakawa T, Takahashi K, Nagakura J, Suzuki J, Sakamoto R, Kadonosono K, Terauchi Y.

Endocr Pract. 2019 Feb;25(2):170-177. doi: 10.4158/EP-2018-0200.

PMID:
30817196
15.

Effect of canagliflozin on the overall clinical state including insulin resistance in Japanese patients with type 2 diabetes mellitus.

Koike Y, Shirabe SI, Maeda H, Yoshimoto A, Arai K, Kumakura A, Hirao K, Terauchi Y.

Diabetes Res Clin Pract. 2019 Mar;149:140-146. doi: 10.1016/j.diabres.2019.01.029. Epub 2019 Feb 1.

16.

A strategy for the reduction of formaldehyde concentration in a hospital pathology laboratory.

Ogawa M, Kabe I, Terauchi Y, Tanaka S.

J Occup Health. 2019 Jan;61(1):135-142. doi: 10.1002/1348-9585.12018.

17.

Humanistic and economic burden of cardiovascular disease related comorbidities and hypoglycaemia among patients with type 2 diabetes in Japan.

Terauchi Y, Ozaki A, Zhao X, Teoh C, Jaffe D, Tajima Y, Shuto Y.

Diabetes Res Clin Pract. 2019 Mar;149:115-125. doi: 10.1016/j.diabres.2019.01.019. Epub 2019 Jan 24.

18.

The Pharmacological Mydriatic Pupil-to-Limbal Diameter Ratio as an Intuitive Predictor for the Risk of Intraoperative Floppy Iris Syndrome.

Terauchi Y, Horiguchi H, Shiba T.

J Ophthalmol. 2018 Dec 20;2018:2837934. doi: 10.1155/2018/2837934. eCollection 2018.

19.

The new basal insulin analog glargine U-300 enables flexible injection schedule.

Osada UN, Terauchi Y.

Ann Transl Med. 2018 Nov;6(Suppl 1):S1. doi: 10.21037/atm.2018.08.25. No abstract available.

20.

Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Obes Metab. 2018 Nov 4. doi: 10.1111/dom.13575. [Epub ahead of print]

21.

Novel Maillard Pigment, Furpenthiazinate, Having Furan and Cyclopentathiazine Rings Formed by Acid Hydrolysis of Protein in the Presence of Xylose or by Reaction between Cysteine and Furfural under Strongly Acidic Conditions.

Noda K, Masuzaki R, Terauchi Y, Yamada S, Murata M.

J Agric Food Chem. 2018 Oct 31;66(43):11414-11421. doi: 10.1021/acs.jafc.8b05302. Epub 2018 Oct 19.

PMID:
30339408
22.

Ligand chirality can affect histidine protonation of vitamin-D receptor: ab initio molecular orbital calculations in water.

Terauchi Y, Suzuki R, Takeda R, Kobayashi I, Kittaka A, Takimoto-Kamimura M, Kurita N.

J Steroid Biochem Mol Biol. 2019 Feb;186:89-95. doi: 10.1016/j.jsbmb.2018.09.020. Epub 2018 Sep 29.

PMID:
30278216
23.

Dietary survey in Japanese patients with type 2 diabetes and the influence of dietary carbohydrate on glycated hemoglobin: The Sleep and Food Registry in Kanagawa study.

Yamakawa T, Sakamoto R, Takahashi K, Suzuki J, Matuura-Shinoda M, Takahashi M, Shigematsu E, Tanaka S, Kaneshiro M, Asakura T, Kawata T, Yamada Y, Osada UN, Isozaki T, Takahashi A, Kadonosono K, Terauchi Y.

J Diabetes Investig. 2019 Mar;10(2):309-317. doi: 10.1111/jdi.12903. Epub 2018 Aug 31.

24.

Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity.

Aoki K, Terauchi Y.

Vitam Horm. 2018;108:355-365. doi: 10.1016/bs.vh.2018.01.008. Epub 2018 Mar 2. Review.

PMID:
30029734
25.

Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Disproportionality Analysis Based on the Japanese Adverse Drug Event Report Database.

Arai M, Shirakawa J, Konishi H, Sagawa N, Terauchi Y.

Diabetes Care. 2018 Sep;41(9):e130-e132. doi: 10.2337/dc18-0210. Epub 2018 Jul 12. No abstract available.

PMID:
30002201
26.

Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus.

Chiba Y, Yamakawa T, Tsuchiya H, Oba M, Suzuki D, Danno H, Takatsuka Y, Shigematsu H, Kaneshiro M, Terauchi Y.

J Clin Med Res. 2018 Aug;10(8):648-656. doi: 10.14740/jocmr3464w. Epub 2018 Jun 27.

27.

SUSTAINable management of type 2 diabetes: feasibility of use and safety of semaglutide.

Shirakawa J, Terauchi Y.

Ann Transl Med. 2018 Apr;6(7):129. doi: 10.21037/atm.2018.01.35. No abstract available.

28.

Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12-month comparison by concomitant sulphonylurea and/or glinide use.

Terauchi Y, Riddle MC, Hirose T, Koyama M, Cheng X, Takahashi Y, Bolli GB.

Diabetes Obes Metab. 2018 Nov;20(11):2541-2550. doi: 10.1111/dom.13414. Epub 2018 Jul 16.

29.

Effect of the sodium-glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages.

Takahashi K, Nakamura A, Miyoshi H, Nomoto H, Kitao N, Omori K, Yamamoto K, Cho KY, Terauchi Y, Atsumi T.

Sci Rep. 2018 May 1;8(1):6864. doi: 10.1038/s41598-018-25126-z.

30.

Correction to: A Randomized Controlled Trial of a Mini Low-Carbohydrate Diet and an Energy-Controlled Diet Among Japanese Patients With Type 2 Diabetes.

Kimura M, Kondo Y, Aoki K, Shirakawa J, Kamiyama H, Kamiko K, Nakajima S, Terauchi Y.

J Clin Med Res. 2018 Jun;10(6):531-534. doi: 10.14740/jocmr3281wc1. Epub 2018 Apr 13.

31.

Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Care. 2018 Jun;41(6):1275-1284. doi: 10.2337/dc17-2224. Epub 2018 Apr 6.

PMID:
29626074
32.

Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry.

Inoue H, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, Koretsune Y, Shimizu W, Tsutsui H, Toyoda K, Hirayama A, Yasaka M, Yamaguchi T, Akishita M, Hasebe N, Kario K, Mizokami Y, Nagata K, Nakamura M, Terauchi Y, Yamamoto T, Teramukai S, Kimura T, Kaburagi J, Takita A.

J Cardiol. 2018 Oct;72(4):300-306. doi: 10.1016/j.jjcc.2018.02.018. Epub 2018 Apr 3.

PMID:
29625717
33.

G protein-coupled receptor 119 agonist DS-8500a effects on pancreatic β-cells in Japanese type 2 diabetes mellitus patients.

Watada H, Shiramoto M, Irie S, Terauchi Y, Yamada Y, Shiosakai K, Myobatake Y, Taguchi T.

J Diabetes Investig. 2019 Jan;10(1):84-93. doi: 10.1111/jdi.12849. Epub 2018 May 4.

34.

Impact of Glucose Loading on Variations in CD4+ and CD8+ T Cells in Japanese Participants with or without Type 2 Diabetes.

Miya A, Nakamura A, Miyoshi H, Takano Y, Sunagoya K, Hayasaka K, Shimizu C, Terauchi Y, Atsumi T.

Front Endocrinol (Lausanne). 2018 Mar 20;9:81. doi: 10.3389/fendo.2018.00081. eCollection 2018.

35.

Efficacy and safety of the G protein-coupled receptor 119 agonist DS-8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo-controlled study.

Terauchi Y, Yamada Y, Watada H, Nakatsuka Y, Shiosakai K, Washio T, Taguchi T.

J Diabetes Investig. 2018 Nov;9(6):1333-1341. doi: 10.1111/jdi.12846. Epub 2018 May 24.

36.

The role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice.

Kitao N, Nakamura A, Miyoshi H, Nomoto H, Takahashi K, Omori K, Yamamoto K, Cho KY, Terauchi Y, Atsumi T.

Metabolism. 2018 Aug;85:48-58. doi: 10.1016/j.metabol.2018.03.010. Epub 2018 Mar 12.

37.

Signaling between pancreatic β cells and macrophages via S100 calcium-binding protein A8 exacerbates β-cell apoptosis and islet inflammation.

Inoue H, Shirakawa J, Togashi Y, Tajima K, Okuyama T, Kyohara M, Tanaka Y, Orime K, Saisho Y, Yamada T, Shibue K, Kulkarni RN, Terauchi Y.

J Biol Chem. 2018 Apr 20;293(16):5934-5946. doi: 10.1074/jbc.M117.809228. Epub 2018 Mar 1.

38.

Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study.

Yamada Y, Terauchi Y, Watada H, Nakatsuka Y, Shiosakai K, Washio T, Taguchi T.

Adv Ther. 2018 Mar;35(3):367-381. doi: 10.1007/s12325-018-0668-2. Epub 2018 Feb 27.

39.

Serum adiponectin and insulin secretion: A direct or inverse association?

Nakamura A, Miyoshi H, Ukawa S, Nakamura K, Nakagawa T, Terauchi Y, Tamakoshi A, Atsumi T.

J Diabetes Investig. 2018 Sep;9(5):1106-1109. doi: 10.1111/jdi.12821. Epub 2018 Mar 25.

40.

Aging-like physiological changes in the skin of Japanese obese diabetic patients.

Ibuki A, Kuriyama S, Toyosaki Y, Aiba M, Hidaka M, Horie Y, Fujimoto C, Isami F, Shibata E, Terauchi Y, Akase T.

SAGE Open Med. 2018 Feb 6;6:2050312118756662. doi: 10.1177/2050312118756662. eCollection 2018.

41.

IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.

Terauchi Y, Sano K, Ainai A, Saito S, Taga Y, Ogawa-Goto K, Tamura SI, Odagiri T, Tashiro M, Fujieda M, Suzuki T, Hasegawa H.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1351-1361. doi: 10.1080/21645515.2018.1438791. Epub 2018 Apr 9.

42.

A Randomized Controlled Trial of a Mini Low-Carbohydrate Diet and an Energy-Controlled Diet Among Japanese Patients With Type 2 Diabetes.

Kimura M, Kondo Y, Aoki K, Shirakawa J, Kamiyama H, Kamiko K, Nakajima S, Terauchi Y.

J Clin Med Res. 2018 Mar;10(3):182-188. doi: 10.14740/jocmr3281w. Epub 2018 Jan 26. Erratum in: J Clin Med Res. 2018 Jun;10 (6):531-534.

43.

Association of usual sleep quality and glycemic control in type 2 diabetes in Japanese: A cross sectional study. Sleep and Food Registry in Kanagawa (SOREKA).

Sakamoto R, Yamakawa T, Takahashi K, Suzuki J, Shinoda MM, Sakamaki K, Danno H, Tsuchiya H, Waseda M, Takano T, Minagawa F, Takai M, Masutani T, Nagakura J, Shigematsu E, Ishikawa M, Nakajima S, Kadonosono K, Terauchi Y.

PLoS One. 2018 Jan 24;13(1):e0191771. doi: 10.1371/journal.pone.0191771. eCollection 2018.

44.

Binder-free sheet-type all-solid-state batteries with enhanced rate capabilities and high energy densities.

Yamamoto M, Terauchi Y, Sakuda A, Takahashi M.

Sci Rep. 2018 Jan 19;8(1):1212. doi: 10.1038/s41598-018-19398-8.

45.
46.

Clinical factors associated with the symptoms of constipation in patients with diabetes mellitus: A multicenter study.

Yamada E, Namiki Y, Takano Y, Takamine H, Inazumi K, Sasaki H, Yamada M, Ito S, Iwasaki T, Mantani N, Minami T, Osada UN, Terauchi Y, Nakajima A.

J Gastroenterol Hepatol. 2018 Apr;33(4):863-868. doi: 10.1111/jgh.14022. Epub 2018 Jan 18.

PMID:
29048762
47.

Serum Quantitative Proteomic Analysis Reveals Soluble EGFR To Be a Marker of Insulin Resistance in Male Mice and Humans.

Kyohara M, Shirakawa J, Okuyama T, Kimura A, Togashi Y, Tajima K, Hirano H, Terauchi Y.

Endocrinology. 2017 Dec 1;158(12):4152-4164. doi: 10.1210/en.2017-00339.

PMID:
29028997
48.

Incretin Kinetics Before and After Miglitol in Japanese Patients With Late Dumping Syndrome.

Amagai M, Tsuchiya H, Chiba Y, Suzuki J, Nagakura J, Shigematsu E, Yamakawa T, Terauchi Y.

J Clin Med Res. 2017 Oct;9(10):879-885. doi: 10.14740/jocmr3135w. Epub 2017 Sep 1.

49.

Galacto-oligosaccharides ameliorate dysbiotic Bifidobacteriaceae decline in Japanese patients with type 2 diabetes.

Gonai M, Shigehisa A, Kigawa I, Kurasaki K, Chonan O, Matsuki T, Yoshida Y, Aida M, Hamano K, Terauchi Y.

Benef Microbes. 2017 Oct 13;8(5):705-716. doi: 10.3920/BM2016.0230. Epub 2017 Sep 8.

PMID:
28884590
50.

Predicting the ability of elderly diabetes patients to acquire the insulin self-injection technique based on the number of animal names recalled.

Minami T, Yamada M, Furuta R, Kamata K, Katsuragawa S, Terui S, Akiyama T, Yoshii T, Tsunoda T, Terauchi Y.

J Diabetes Investig. 2017 Aug 28. doi: 10.1111/jdi.12732. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center